Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Hair restoration surgeons must understand the differences between CTE and FPHL for accurate diagnosis and treatment.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

Gene differences may affect baldness treatment response in Korean men.

Chromosomal differences affect how muscle cells respond to testosterone.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The study found clear differences in lesion distribution and microscopic features among trichostasis spinulosa, keratosis pilaris, and eruptive vellus hair cysts.

The document found differences in lesion distribution and microscopic features among trichostasis spinulosa and similar skin conditions.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Dermatologists can accurately detect smaller differences in hair density than previously thought.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Skin aging is largely due to differences in stiffness and elasticity between skin layers, leading to wrinkles.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Certain drugs, especially those for eyes, bacterial infections, imaging tests, and skin conditions, are more likely to cause itching, with differences seen across gender, age, and weight.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Men may have a condition similar to PCOS, possibly indicated by early hair loss.

Sex hormones affect brain injury differently in males and females.